Specialist add-ons

Specialist development add-ons

Product- and population-specific controls that extend the Stage 0-9 drug-development system.

What this stage covers

Biologics, ATMP, oncology, paediatric, rare-disease, vaccine, and combination-product development.

How it helps your team: Identify specialised controls while preserving a consistent operational foundation.

7 toolkits

Choose the operational area you need

Extend the core development system with biologics-specific CMC, immunogenicity, species relevance, comparability, viral safety, and potency controls.

Extend the core system with ATMP-specific regulatory, identity, custody, long-term follow-up, CMC, and source-traceability controls.

Extend the core system with oncology-specific dose escalation, DLT, response assessment, combination risk, and safety-review controls.

Extend the core system with paediatric planning, commitments, consent and assent, safety monitoring, and age-appropriate formulation controls.

Extend the core system with orphan strategy, natural-history, registry, small-population, external-control, and evidence-assumption controls.

Extend the core system with vaccine-specific clinical safety, immunogenicity, lot consistency, submission, and special-population controls.

Extend the core system with combination-product planning, human factors, complaint-to-PV interfaces, risk management, and pathway controls.

Return to the full catalogue and search by process, study, submission or control.